Common Contracts
2 similar Grant Agreement contracts
GRANT AGREEMENTGrant Agreement • May 3rd, 2022
This Grant Agreement (“Agreement”) is entered into as of 10th of April 2022 (“Effective Date”) by and between Novartis Healthcare A/S, Reg. No. 20575786, a company incorporated under the laws of Denmark, located at Edvard Thomsens Vej 14, DK-2300 Copenhagen S, Denmark (“Novartis”) and Hudsagen (CVR no. 81935319) in collaboration with Rud Pedersen Public Affairs (CVR no. 31362814), an organization and a company, respectively, incorporated under the laws of Denmark, located at Blekinge Boulevard 2, DK-2630 Taastrup and Ved Stranden, DK-1061 Copenhagen K, (collectively referred to as “Grant Recipient”). Novartis and Grant Recipient may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
GRANT AGREEMENTGrant Agreement • August 24th, 2021
This Grant Agreement (“Agreement”) is entered into as of 24th of August 2021 (“Effective Date”) by and between Novartis Healthcare A/S, Reg. No. 20575786, a company incorporated under the laws of Denmark, located at Edvard Thomsens Vej 14, DK-2300 Copenhagen S, Denmark (“Novartis”) and Hudsagen (CVR no. 81935319) in collaboration with Rud Pedersen Public Affairs (CVR no. 31362814), an organization and a company, respectively, incorporated under the laws of Denmark, located at Blekinge Boulevard 2, DK-2630 Taastrup and Ved Stranden, DK-1061 Copenhagen K, (collectively referred to as “Grant Recipient”). Novartis and Grant Recipient may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
